Vabicaserin hydrochloride

CAS No. 887258-94-8

Vabicaserin hydrochloride ( SCA 136 )

Catalog No. M24909 CAS No. 887258-94-8

Vabicaserin hydrochloride is a selective agonist of 5-hydroxytryptamine 2C (5-HT2C) receptor (EC50: 8 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 335 In Stock
10MG 500 In Stock
25MG 806 In Stock
50MG 1098 In Stock
100MG 1485 In Stock
500MG 2961 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Vabicaserin hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Vabicaserin hydrochloride is a selective agonist of 5-hydroxytryptamine 2C (5-HT2C) receptor (EC50: 8 nM).
  • Description
    Vabicaserin hydrochloride is a selective agonist of 5-hydroxytryptamine 2C (5-HT2C) receptor (EC50: 8 nM).
  • Synonyms
    SCA 136
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT2C
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    887258-94-8
  • Formula Weight
    264.8
  • Molecular Formula
    C15H21ClN2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:75 mg/mL (283.24 mM; Need ultrasonic); H2O:4 mg/mL (15.11 mM; Need ultrasonic)
  • SMILES
    C(C[C@H]1C2)C[C@@H]1c1c3N2CCNCc3ccc1.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Dunlop J, et al. Characterization of Vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist. J Pharmacol Exp Ther. 2011 Jun;337(3):673-80.
molnova catalog
related products
  • Dexchlorpheniramine ...

    Dexchlorpheniramine (trade name Polaramine) is an antihistamine with anticholinergic properties used to treat allergic conditions such as hay fever or urticaria.

  • Eletriptan

    Eletriptan (UK 116044) is a potent, selective, and orally active 5-HT1B/1D receptor agonist.

  • Lurasidone hydrochlo...

    Lurasidone is an atypical antipsychotic developed by Dainippon Sumitomo Pharma.